A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

How, Jonathan; Minden, Mark D.; Brian, Leber; Chen, Eric X.; Brandwein, Joseph; Schuh, Andre C.; Schimmer, Aaron D.; Gupta, Vikas; Webster, Sheila; Degelder, Tammy; Haines, Patricia; Stayner, Lee-Anne; McGill, Shauna; Wang, Lisa; Piekarz, Richard; Wong, Tracy; Siu, Lillian L.; Espinoza-Delgado, Igor; Holleran, Julianne L.; Egorin, Merrill J.; Yee, Karen W. L.

Published in

Taylor and Francis Group, Leukemia & Lymphoma, 10(56), p. 2793-2802

DOI: 10.3109/10428194.2015.1018248

Tools

Export citation

Search in Google Scholar

A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

Journal article published in 2015 by Jonathan How, Mark D. Minden, Leber Brian, Eric X. Chen, Joseph Brandwein, Andre C. Schuh, Aaron D. Schimmer, Vikas Gupta

, Sheila Webster, Tammy Degelder, Patricia Haines, Lee-Anne Stayner, Shauna McGill, Lisa Wang, Richard Piekarz and other authors.

This paper is available in a repository.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia